Moreover, regarding Alzheimer’s disease (AD), a multifactorial aging-related brain disorder, decreased transcript levels of gstm3 in AD have been reported to affect hippocampus and peripheral blood mononuclear cells [70,71]. This evidence concerns the gene GSTM3 and Alzheimer disease.